Researchers investigate Cortisol's role in rare fat disorder

NCT ID NCT04845165

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how the body processes cortisol in people with a rare genetic condition called familial partial lipodystrophy type 2 (FPL2). The goal was to see if increased activity of a certain enzyme (11β-HSD1) contributes to the severe metabolic problems seen in this disease. Researchers measured cortisol-related substances in urine and checked enzyme activity in fat tissue from 25 participants. The findings may help understand the disease better but do not test any treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL PARTIAL LIPODYSTROPHY TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

familial partial lipodystrophy familial partial lipodystrophy, Dunnigan type hypertriglyceridemia Insulin Resistance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hop Claude Huriez

    Lille, 59037, France